0GZK.LSE Ion Beam Applications S.A.

Healthcare Commercial Services & Supplies London Exchange
16.92 EUR
Close of Nov 3, 2026
9.81 17.72
Market cap
EUR 496M
P/E
131.6x
P/B
-
ROE
-
Dividend yield
0.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is 0GZK.LSE undervalued?

Graham number

The Graham number of Ion Beam Applications S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ion Beam Applications S.A. fundamental analysis

No fundamental analysis for Ion Beam Applications S.A. yet.

Ion Beam Applications S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ion Beam Applications S.A.

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak; DynamicARC, a technique that allows dynamic spot scanning irradiation …

Full company profile